Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 1.29 CAD 0.78% Market Closed
Market Cap: 373m CAD

Spectral Medical Inc
Accounts Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Spectral Medical Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Spectral Medical Inc
TSX:EDT
Accounts Receivables
CA$433k
CAGR 3-Years
76%
CAGR 5-Years
6%
CAGR 10-Years
-5%
Theratechnologies Inc
TSX:TH
Accounts Receivables
$11m
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
13%
Repare Therapeutics Inc
NASDAQ:RPTX
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accounts Receivables
$30.7m
CAGR 3-Years
-10%
CAGR 5-Years
95%
CAGR 10-Years
77%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Accounts Receivables
$812k
CAGR 3-Years
-31%
CAGR 5-Years
-13%
CAGR 10-Years
10%
Willow Biosciences Inc
TSX:WLLW
Accounts Receivables
CA$7k
CAGR 3-Years
-59%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
No Stocks Found

Spectral Medical Inc
Glance View

Market Cap
373m CAD
Industry
Biotechnology

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 31 full-time employees. The firm has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The firm through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.

EDT Intrinsic Value
HIDDEN
Show

See Also

What is Spectral Medical Inc's Accounts Receivables?
Accounts Receivables
433k CAD

Based on the financial report for Sep 30, 2025, Spectral Medical Inc's Accounts Receivables amounts to 433k CAD.

What is Spectral Medical Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-5%

Over the last year, the Accounts Receivables growth was 28%. The average annual Accounts Receivables growth rates for Spectral Medical Inc have been 76% over the past three years , 6% over the past five years , and -5% over the past ten years .

Back to Top